Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study

Abstract

ObjectiveMedication adherence is impacted by regimen complexity. The SIMPLE (Simple basal Insulin titration, Metformin Plus Liraglutide for type 2 diabetes with very Elevated HbA1c) study compared GLP1RA plus basal insulin (GLP1RA+BI) to basal-bolus insulin (BBI) regimen in participants with very uncontrolled type 2 diabetes mellitus (T2DM). This analysis aimed to evaluate medication adherence to GLP1RA+BI compared with BBI, the effect of adherence on clinical and patient-reported outcomes, and baseline predictors of adherence.Research design and methodsThis was an analysis of the SIMPLE study based on prespecified outcome. The study took place in pragmatic, real-world setting. A total of 120 adults with T2DM and HgbA1c≥10% were randomized to detemir plus liraglutide, or detemir plus aspart before each meal; 6-month follow-up. The main outcomes evaluated were: adherence, HgbA1c, weight, quality of life, and hypoglycemia. Adherence rate was calculated for each study medication at each follow-up visit; participants were classified as ≥80% or <80% adherent.ResultA higher percentage of participants in the GLP1RA+BI compared with the BBI group had ≥80% adherence to detemir (59.3% vs 35.7%, p=0.02) as well as liraglutide versus aspart (57.4% vs 30.4%, p=0.007). Higher age was predictive of ≥80% adherence (OR per 5-year increment=1.48, 95% CI 1.09 to 2.0, p=0.01). Higher adherence led to greater improvement in HbA1c and weight in both groups. Treatment with GLP1RA+BI compared with BBI led to greater improvement in HbA1c, weight, and quality of life and lower risk of hypoglycemia even after adjusting for the difference in adherence between groups.ConclusionsAdherence was higher with the simplified regimen of GLP1RA+BI compared with BBI. Greater adherence to the simpler regimen amplified the treatment effect on HbA1c, weight, quality of life, and risk of hypoglycemia, yet statistically significant greater benefits were noted even when adjusted for adherence.Trial registration numberNCT01966978

Glycemic control and its determinants among patients with type 2 diabetes mellitus at Menelik II Referral Hospital, Ethiopia

“…This study found that compliance with medication was not associated with blood glucose control to a significant level. The finding of this study contradicts a study done in the United States, Texas, where good medication adherence was a predictor of good glycemic control, 26 and a study done in Jordan where poor blood glucose control was common among those patients with medication non-adherence. 21 In this study, it was also found that compliance with exercise and smoking was not associated with glucose control.…”

Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey

“…Good adherence to metformin improves clinical outcomes (Nathan et al, 2006;Patel et al, 2019;Walker et al, 2020). Randomized controlled trials and systematic reviews FIGURE 1 | Responses to knowledge questions "the correct dosage range of metformin XR," "the frequency of metformin XR," "the proper timing of metformin XR administration."…”

Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents

“…In addition, adherence to treatment with oral hypoglycemic agents and insulin therapy ranges between 36%-93% and between 20%-80%, respectively[ 97 ]. Several factors, such as complexity of treatment, have been implicated in low adherence in adults with T2DM[ 98 ]. What seems to be very important in both adult and adolescent populations though, is psychological factors such as depression and anxiety[ 99 , 100 ].…”